2015年 IAAO

国際フォーラム2015(IAAO2015)

Theme:Forefront of Oncology Care: Discovery, Development and HTA

Opening Remarks

201201 Osamu Nagayama, Chairman
Chugai Academy for Advanced Oncology

1. Epigenetics

▶ Epigenetic Therapy – A Means to Prime for Responses to Immune Checkpoint and Other Cancer Therapies?

2_Baylin_A00149S
Speaker:
Stephen B. Baylin, MD
Johns Hopkins University, USA
Chair:
Chikashi Ishioka, MD
Tohoku University, Japan
3_Ishioka_B0091S

Targeting Epigenetic Mechanisms in Cancer

4_Armstrong_A00222S
Speaker:
Scott Armstrong, MD, PhD
Memorial Sloan-Kettering Cancer Center, USA
Chair:
Kiyohiko Hatake, MD, PhD
Cancer Institute Hospital, Japan
5_Hatake_A00274S

2. Molecular Targets and Therapy

Comprehensive Genomic Profiles of Small Cell Lung Cancer and Other Pulmonary Neuroendocrine Tumors

6_George_A00338S
Speaker:
Julie George, PhD
University of Cologne, Germany
Chair:
Hiroyuki Mano, MD, PhD
The University of Tokyo, Japan
7_Mano_A00291S

The Evolution of Genotypic Characterization and Targeted Therapy in Lung Cancer

8_Johnson_A00399S
Speaker:
Bruce E. Johnson, MD
Harvard Medical School, USA
Chair:
Mitsuaki Yoshida, PhD
Japanese Foundation For Cancer Research, Japan
9_Yoshida_B0350S

3. Radiation and Thyroid Cancer

Radiation and Thyroid Cancer; lessons learned from Hiroshima, Nagasaki and Chernobyl to Fukushima

10_Yamashita_A00551S
Speaker:
Shunichi Yamashita, MD, PhD
Nagasaki University, Japan
Chair:
James A. Fagin, MD
Memorial Sloan-Kettering Cancer Center, USA
11_Fagin_A00544S

Molecular Pathogenesis of Radiation-Induced and Sporadic Thyroid Cancers: Implications for Mechanism-Based Therapies

12_Fagin_A00643S
Speaker:
James A. Fagin, MD
Memorial Sloan-Kettering Cancer Center, USA
Chair:
Shunichi Yamashita, MD, PhD
Nagasaki University, Japan
13_Yamashita_C_00161S

4. Progress in Breast Cancer Therapy

Hormone Resistant Breast Cancer

13_Chandarlapaty_A00714S
Speaker:
Sarat Chandarlapaty, MD, PhD
Memorial Sloan-Kettering Cancer Center, USA
Chair:
Masakazu Toi, MD, PhD
Kyoto University, Japan
14_Toi_C_00287S

Translational Approaches to Optimizing Breast Cancer Therapy

15_Ellisen_A00821B
Speaker:
Leif Ellisen, MD, PhD
Harvard Medical School, USA
Chair:
Yuko Kitagawa, MD, PhD
Keio University, Japan
16_Kitagawa_C_00532S

5. “Usefulness” of New Medicines

Dealing with the Successes and Failures of Targeted Therapy

 

17_Chabner_A00886S
Speaker:
Bruce A. Chabner, MD
Harvard Medical School, USA
Chair:
Makoto Ogawa, MD
Aichi Cancer Center, Japan
18_Ogawa_A00862S

Health Technology Assessment in Cancer: Driving Eciency and Efficacy, but at what cost?

19_Johnston_A00959S
Speaker:
Patrick Johnston, MD, PhD
Queen’s University Belfast, UK
Chair:
Yasuhiro Fujiwara, MD, PhD
National Cancer Center, Japan
20_Fujiwara_A00978S

6. Tumor Immunotherapy

Immunotherapy for Lung Cancer and New Treatment Paradigm

21_Sandler_A01010S
Speaker:
Alan B. Sandler, MD
Genentech Inc., USA
Chair:
Nagahiro Saijo, MD, PhD
Japanese Society of Medical Oncology, Japan
22_Saijo_A01049S

CAR Therapy: The CD19 Paradigm and Beyond

23_Sadelain_A01121S
Speaker:
Michel Sadelain, MD, PhD
Memorial Sloan-Kettering Cancer Center, USA
Chair:
Ryuzo Ueda, MD, PhD
Aichi Medical University, Japan
24_Ueda_A01145S
一般社団法人 中外Oncology学術振興会議